The manufacturer became aware of an allegation of af541 capstrap that the patient alleges during clinical and therapeutic use, it was noted that the access/entrainment port on the non-invasive interface was opened, resulting in an unanticipated leak in the system.The patient suffered a desaturation of peripheral oxygenation (unspecified), increased heart rate (unspecified), and multiple seizures.The port on the interface was closed and therapy settings titrated with recovery of the patient noted.The patient is still currently utilizing the device.There is no allegation of serious or permanent harm or injury.No medical intervention was required by the patient.The manufacturer's investigation is ongoing.A follow-up report will be submitted when the manufacturer's investigation is complete.
|